Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/183106
Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Patients with certain immune-mediated inflammatory diseases, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD), have an increased risk of severe infectious diseases than the general population, which are mainly associated with the immunosuppressive treatments that they receive.
These treatments act on the immune system through different mechanisms, causing different degrees of immunosuppression and a variable risk depending on whether the pathogen is a virus, bacteria or fungus. This article reviews the most relevant literature on the subject, which was selected and discussed by a panel of experts. The aim of this article is to review the risk of infections in patients with IBD and RA, and the potential preventive measures. (C) 2021 The Author(s). Published by Elsevier Espana, S.L.U.
Matèries (anglès)
Citació
Calvet, X., Carpio, D., Rodríguez-Lago, I., García-Vicuña, R., Barreiro-de-Acosta, M., Juanola, X., ... & Gratacós, J. (2021). Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies. Gastroenterología y Hepatología (English Edition), 44(8), 587-598.
Citació
CALVET, Xavier, CARPIO, Daniel, RODRIGUEZ LAGO, Iago, GARCIA VICUÑA, Rosario, BARREIRO DE ACOSTA, Manuel, JUANOLA, Xavier, AGUAS, Mariam, CASTILLO, Concepción, GRATACÓS MASMITJÀ, Jordi. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies. _Gastroenterología y Hepatología (English Edition)_. 2021. Vol. vol 44, núm. num 8, pàgs. 587-598. [consulta: 21 de gener de 2026]. ISSN: 2444-3824. [Disponible a: https://hdl.handle.net/2445/183106]